Home › NDC Lookup › Ingredients › Salicylic Acid › 70381-0134-02
🧴image loading
(from DailyMed)

Biome-Balancing Clear and Prevent Acne (Blemish) Treatment Serum Salicylic Acid 1 g/100mL Solution — NDC 70381-134-02 (Billing 70381-0134-02)

by Murad, LLC · 1 BOTTLE in 1 CARTON / 30 mL in 1 BOTTLE

This is a package of Biome-Balancing Clear and Prevent Acne (Blemish) Treatment Serum Salicylic Acid 1 g/100mL Solution from Murad, LLC, marketed since Mar 2025 and currently FDA-listed. It is this product's only package size.

NDC 70381-0134-02
🏷️ FDA NDC (as labeled) 70381-134-02 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 70381-134-02 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
70381 labeler · 134 product · 02 package
Package marketed since
Mar 24, 2025
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 7038113402 2
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70381-134-02
Product NDC 70381-134
11-digit billing NDC 70381013402
RxCUI 1047362
UNII O414PZ4LPZ
Application # M006
SPL Set ID 3709208a-5550-4819-b923-a883878737bb
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-03-24
Route TOPICAL
Dosage form SOLUTION
Substance SALICYLIC ACID
Quick answers
  • RxCUI (RxNorm): 1047362
Why two NDCs? The FDA registers this code as 70381-134-02 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 70381-0134-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Salicylic acid and derivatives class.

Drug family (ATC) Salicylic acid and derivatives, Other antifungals for topical use, Antiinflammatory agents, non-steroids
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It is used in a facial routine for acne-prone and oil-prone skin. The routine includes a cleanser, serum, toner and emulsion. Salicylic acid helps loosen and shed dead skin cells.
  • Use the cleanser morning and evening, and the serum in the morning after cleansing. Use the toner in the evening on dry skin, and the emulsion at night after cleansing. Avoid your...
  • Mild stinging, burning, itching, dryness and extra peeling can happen. If dryness or peeling bothers you, try using the serum or toner every other day. If it gets excessive, stop a...
  • It is best not to. Using another topical acne medication at the same time makes irritation and dryness more likely. If you get irritated, use only one at a time.
📖 Read our full Salicylic Acid Topical guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70381-0134-02 You're viewing this Main listing 1 BOTTLE in 1 CARTON / 30 mL in 1 BOTTLE 2025-03-24 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
ARTISTRY STUDiO Rose All Day Anti Acne Toner Pore Refresher 10 mg/mL 10056-0410-00 Access 200 ml — — FDA listed —
Biore 1 g/100g 10596-0199-05 Kao 1 tube — — FDA listed —
NAS Toner 1 g/1001 26052-0042-01 BURT'S 145 liquids — — FDA listed —
Clarifying Toner 1 g/100g 62742-4240-01 Allure 120 g — — FDA listed —
Biome-Balancing Clear and Prevent Acne (Blemish) Treatment Serum 1 g/100mLthis 70381-0134-02 Murad, 1 bottle — — FDA listed —
Aftaseptic Instant Pain Relief 10 mg/mL 73635-7102-05 Germa 1 bottle — — FDA listed —
Dr. C. Tuna Acne Blemish Control Serum 10 mg/mL 74690-0011-01 Farmasi 1 bottle — — FDA listed —
YOUR Anti Acne Serum .2 g/20mL 84229-0016-00 Skin 20 ml — — Discontinued —
Your Anti-Acne Serum .2 g/20mL 84229-2101-03 Skin 1 ml — — FDA listed —
Wart Remover 1 g/100mL 84302-0001-01 Shenzhen 30 ml — — Discontinued —
Sylvirene Milia Remover 1 g/100mL 85248-0071-01 Jiangxi 40 ml — — FDA listed —
Beilloso FACIAL BUMP REFINING ESSENCE 1 g/100mL 85248-0077-01 Jiangxi 30 ml — — FDA listed —
Serynth Milia Remover 1 g/100mL 85248-0107-01 Jiangxi 30 ml — — FDA listed —
Dermfree Milia Remover 1 g/100mL 85248-0125-01 Jiangxi 30 ml — — FDA listed —
Folupia Milia Remover 1 g/100mL 85248-0147-01 Jiangxi 30 ml — — FDA listed —
Flobow FACIAL BUMP REFINING ESSENCE 1 g/100mL 85248-0168-01 Jiangxi 30 ml — — FDA listed —
Lixuhya MILIA REMOVER ESSENCE 1 g/100mL 85248-0208-01 Jiangxi 40 ml — — FDA listed —
Butterflys tear MILIA REMOVER 1 g/100mL 85248-0213-01 Jiangxi 30 ml — — FDA listed —
Blemish Blitz Emergency Acne Serum .01 g/mL 85779-0003-01 Guangdong 20 ml — — FDA listed —
Milia remover .01 g/mL 87278-0006-01 Guangxi 30 ml — — FDA listed —
Xexlvov Milia Remover 1 g/100mL 87312-0147-01 Shanghai 30 ml — — FDA listed —
Byt Bangytong Milia Remover 1 g/100mL 87382-0107-01 Shenzhen 30 ml — — FDA listed —
Spesolskii Milia Remover Essence 1 g/100mL 87556-0001-01 BEST 30 ml — — FDA listed —
Asterose Wart Remover 1 g/100mL 87786-0003-01 Wenzhou 10 ml — — FDA listed —
Musizlee WART REMOVER 1 g/100mL 87786-0004-01 Wenzhou 10 ml — — FDA listed —
Stridex Essential 1 g/100mL 10157-2119-01 Blistex 1 jar — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Mar 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Salicylic Acid Topical inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerMurad, LLC
FDA applicationM006 (OTC MONOGRAPH DRUG)
Labeler code70381
First marketedMar 2025
Product typeHuman Otc Drug
Portfolio12 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 6 words ▾

Use for the management of acne

⏱️ Dosage and Administration 68 words ▾

Directions clean the skin thoroughly before applying product cover the entire affected area with a thin layer one to three times daily because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day

⚠️ Warnings 62 words ▾

Warnings For external use only When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 19 words ▾

Other information store at room temperature avoid high temperatures protect from freezing keep away from flame, fire and heat

🧪 Active Ingredient 5 words ▾

Active ingredients Salicylic Acid 1.0%

🧪 Inactive Ingredients 103 words ▾

Inactive ingredients Water (Aqua), Propanediol, Mandelic Acid, Glycerin, Erythritol, Pentylene Glycol, Sodium Polyacryloyldimethyl Taurate, Dimethicone, Sodium Hydroxide, Saccharide Isomerate, Glutamic Acid, Allantoin, Punica Granatum Pericarp Extract, Nelumbo Nucifera Flower Extract, Nymphaea Caerulea Flower Extract, Urea, Yeast Amino Acids, Trehalose, Inositol, Taurine, Betaine, Melia Azadirachta Leaf Extract, Melia Azadirachta Flower Extract, Corallina Officinalis Extract, Coccinia Indica Fruit Extract, Aloe Barbadensis Flower Extract, Solanum Melongena (Eggplant) Fruit Extract, Ocimum Basilicum (Basil) Flower/Leaf Extract, Curcuma Longa (Turmeric) Root Extract, Ocimum Sanctum Leaf Extract, Maltodextrin, Glyceryl Polyacrylate, Polysilicone-11, Butylene Glycol, Decyl Glucoside, Tetrasodium Glutamate Diacetate, Citric Acid, Sodium Citrate, 1,2-Hexanediol, Leuconostoc/Radish Root Ferment Filtrate, Caprylyl Glycol, Chlorphenesin

🎯 Purpose 3 words ▾

Purpose Acne Treatment

📄 When Using This Product 36 words ▾

When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 6 words ▾

Questions or comments? 1.310.765.1520 or Murad.com

📄 Package Label / Principal Display Panel 44 words ▾

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton Murad ® ACNE CONTROL Biome-Balancing Clear & Prevent Acne Treatment Serum with complexion-smoothing mandelic acid 1.0% salicylic acid acne treatment ℮ 30 mL NET VOL

1.0 FL OZ PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Salicylic Acid (matched by generic name) — the program that covers self-administered drugs. 2 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Salicylic Acid. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$11.2K
Claims incl. refills
43
Beneficiaries
35
Spend / beneficiary
$319.01
Spend / claim
$259.66
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Biome-Balancing Clear and Prevent Acne (Blemish) Treatment Serum (this brand).

Top reported reactions

Vomiting216
Pruritus205
Weight Decreased188
Condition Aggravated184
Urticaria184
Weight Increased183
Hypertension181

Reporter sex

0 reports

Serious outcomes

Hospitalization622
Reports over time (by year) — tap or hover for the count & year
2021 2022 2024 2026 252 93
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Murad, LLC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Murad, LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.